Michael Myers - 09 Dec 2024 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Myers
Issuer symbol
QNRX
Transactions as of
09 Dec 2024
Net transactions value
$0
Form type
4
Filing time
10 Dec 2024, 16:47:01 UTC
Previous filing
05 Sep 2024
Next filing
27 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNRX Share Option (Right to Buy) Award $0 +536,603 $0.000000 536,603 09 Dec 2024 ADS 536,603 $0.7800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
F2 The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028.